Latest Partnerships News

Vmoto Limited disclosed it held only one formal board meeting in FY25, relying heavily on circular resolutions, and outlined plans to increase meeting frequency in 2026. The company clarified its trade insurance arrangements and affirmed director independence amid ASX queries.

TrivarX has contracted Beyond Drug Development to drive its Stabl-Im MRI imaging platform into Phase 1 trials, aiming to start safety testing in healthy volunteers by late 2026.

Godolphin Resources is spinning out its Narraburra Rare Earths Project into a new ASX-listed entity, Matrix Critical Minerals, with MST Financial appointed to spearhead the IPO expected in the second half of 2026.

HIQ Limited has locked in non-dilutive funding from the Victorian Government to underpin a $4.9 million project expanding its manufacturing and research footprint in Victoria, supporting its global growth ambitions.

Tivan Limited has formalised binding joint venture agreements with Timor-Leste’s state-owned Murak Rai Timor to develop the Baucau and Ossu copper-gold projects, targeting maiden drilling at Ossu in late 2026.

Bendigo and Adelaide Bank reported a slight increase in its Common Equity Tier 1 ratio to 11.38% for the quarter ended March 2026, driven by net profit and capital inflows. Risk-weighted assets rose 1.75%, largely due to loan portfolio expansion and a new operational risk capital overlay.

Guzman y Gomez has abruptly exited the US market, citing financial underperformance despite brand progress, while reaffirming strong Australian growth and international franchise confidence.

Vitrafy Life Sciences has achieved a major validation milestone with US Army-backed Phase II results showing its no-wash platelet cryopreservation protocol delivers 94% post-thaw recovery, outperforming existing standards and advancing FDA registration plans.

Monadelphous has landed $120 million worth of new contracts spanning resources and renewable energy, including a key battery storage project for Fortescue and expanded services for Rio Tinto.

Legacy Minerals has delivered a robust Scoping Study for its Mt Carrington gold-silver-copper project, confirming a high-margin 12-year operation with significant growth potential and manageable capital requirements.

Avecho Biotechnology has wrapped up the treatment phase for its pivotal Phase III insomnia trial involving 244 participants, setting the stage for an interim efficacy analysis expected in late June 2026.

Findi Limited lowers its FY26 operating revenue and EBITDA guidance, citing integration costs and funding delays, but reports operational improvements following a $25 million equity raise and appoints a new Chief Commercial Officer.